bf/NASDAQ:BIOL_icon.jpeg

COM:BIOLASE

BIOLASE

  • Stock

Last Close

0.02

02/10 20:00

Market Cap

2.84M

Beta: -

Volume Today

2.67M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
56.43M
-
47.66M
15.55%
48.48M
1.72%
51.81M
6.88%
46.93M
9.43%
46.16M
1.64%
37.80M
18.10%
22.78M
39.73%
39.19M
72.03%
48.46M
23.67%
49.16M
1.45%
cost of revenue
34.90M
-
29.48M
15.52%
32.52M
10.31%
31.50M
3.15%
31.80M
0.95%
29.26M
7.99%
23.51M
19.65%
16.61M
29.36%
22.66M
36.44%
32.55M
43.66%
32.44M
0.34%
gross profit
21.53M
-
18.17M
15.60%
15.95M
12.23%
20.31M
27.32%
15.13M
25.52%
16.89M
11.70%
14.29M
15.43%
6.17M
56.80%
16.53M
167.76%
15.91M
3.74%
16.72M
5.11%
selling and marketing expenses
18.68M
-
16.38M
12.35%
18.70M
14.17%
17.02M
8.98%
16.72M
1.76%
18.12M
8.39%
14.40M
20.56%
11.24M
21.91%
15.34M
36.44%
21.68M
41.31%
18.44M
14.92%
general and administrative expenses
9.38M
-
14.85M
58.41%
10.26M
30.95%
10.45M
1.92%
9.71M
7.09%
11.77M
21.20%
10.75M
8.69%
9.77M
9.08%
11.26M
15.21%
12.31M
9.34%
10.22M
17.00%
selling general and administrative expenses
28.06M
-
31.23M
11.30%
28.95M
7.29%
27.47M
5.12%
26.43M
3.79%
29.89M
13.10%
25.14M
15.88%
21.01M
16.43%
26.60M
26.57%
33.98M
27.77%
28.66M
15.68%
research and development expenses
4.03M
-
4.58M
13.60%
7.28M
59.12%
7.80M
7.08%
6.23M
20.13%
5.20M
16.47%
4.76M
8.42%
3.69M
22.46%
6.05M
63.68%
7.26M
20.12%
6.00M
17.36%
other expenses
438K
-
307K
29.91%
361K
17.59%
4.21M
-
cost and expenses
67.43M
-
65.60M
2.71%
69.12M
5.37%
66.77M
3.40%
64.46M
3.46%
64.36M
0.16%
53.42M
16.99%
41.32M
22.66%
55.30M
33.86%
73.80M
33.44%
67.10M
9.08%
operating expenses
32.53M
-
36.11M
11.03%
36.60M
1.34%
35.27M
3.62%
32.66M
7.40%
35.09M
7.46%
29.91M
14.78%
24.71M
17.39%
32.65M
32.12%
41.25M
26.36%
34.66M
15.97%
interest expense
600K
-
458K
23.67%
-546K
219.21%
258K
147.25%
-100K
138.76%
510K
610%
2.16M
322.94%
2.36M
9.36%
2.22M
5.72%
2.75M
23.61%
2.36M
14.11%
ebitda
-11.00M
-
-17.94M
63.16%
-21.12M
17.71%
-13.58M
35.69%
-16.39M
20.66%
-17.25M
5.29%
-14.64M
15.16%
-13.82M
5.58%
-15.72M
13.70%
-24.84M
58.06%
-15.14M
39.06%
operating income
-11.00M
-
-17.94M
63.16%
-19.91M
11.00%
-14.96M
24.87%
-18.04M
20.56%
-20.89M
15.78%
-15.62M
25.20%
-18.54M
18.66%
-16.12M
13.06%
-25.34M
57.22%
-17.94M
29.21%
depreciation and amortization
601K
-
696K
15.81%
880K
26.44%
1.05M
19.09%
1.20M
14.79%
945K
21.45%
982K
3.92%
4.71M
380.04%
400K
91.51%
497K
24.25%
2.80M
462.98%
total other income expenses net
-50K
-
-415K
730%
472K
213.73%
-332K
170.34%
58K
117.47%
-2.74M
4,829.31%
-2.28M
16.95%
1.83M
180.55%
23K
98.75%
-3.19M
13,956.52%
-2.66M
16.41%
income before tax
-11.65M
-
-18.81M
61.55%
-20.10M
6.84%
-15.22M
24.28%
-17.43M
14.54%
-21.45M
23.06%
-17.90M
16.57%
-16.70M
6.69%
-16.09M
3.64%
-28.52M
77.25%
-20.60M
27.78%
income tax expense
-164K
-
112K
168.29%
178K
58.93%
151K
15.17%
-582K
485.43%
63K
110.82%
-44K
169.84%
128K
390.91%
65K
49.22%
109K
67.69%
31K
71.56%
net income
-11.48M
-
-18.93M
64.83%
-20.28M
7.14%
-15.37M
24.20%
-16.85M
9.63%
-21.52M
27.68%
-17.86M
17.02%
-16.83M
5.75%
-16.16M
3.99%
-28.63M
77.21%
-20.63M
27.95%
weighted average shs out
2.79K
-
3.60K
28.90%
4.66K
29.34%
4.85K
4.25%
5.90K
21.57%
8.23K
39.58%
928.04K
11,169.46%
2.44M
163.46%
5.91M
141.72%
6.93M
17.26%
1.28M
81.56%
weighted average shs out dil
2.79K
-
3.60K
28.90%
4.66K
29.34%
4.85K
4.25%
5.90K
21.57%
8.23K
39.58%
928.04K
11,169.46%
2.44M
163.46%
5.91M
141.72%
6.93M
17.26%
1.28M
81.56%
eps
-4.11K
-
-5.26K
27.87%
-4.36K
17.16%
-3.17K
27.29%
-2.86K
9.83%
-2.61K
8.52%
-19.24
99.26%
-6.88
64.24%
-2.73
60.32%
-4.13
51.28%
-16.14
290.80%
epsdiluted
-4.11K
-
-5.26K
27.87%
-4.36K
17.16%
-3.17K
27.29%
-2.86K
9.83%
-2.61K
8.52%
-19.24
99.26%
-6.88
64.24%
-2.73
60.32%
-4.13
51.28%
-16.14
290.80%

All numbers in (except ratios and percentages)